Literature DB >> 15794951

Vaccine trial as "probe" to define the burden of pneumococcal pneumonia disease.

Marilla G Lucero1, Gail Williams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15794951     DOI： 10.1016/S0140-6736(05)71853-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Economic evaluation of pneumococcal conjugate vaccination in The Gambia.

Authors:  Sun-Young Kim; Gene Lee; Sue J Goldie
Journal:  BMC Infect Dis       Date:  2010-09-03       Impact factor: 3.090

2.  High pneumonia lifetime-ever incidence in Beijing children compared with locations in other countries, and implications for national PCV and Hib vaccination.

Authors:  Fang Qu; Louise B Weschler; Yuexia Sun; Jan Sundell
Journal:  PLoS One       Date:  2017-02-06       Impact factor: 3.240

3.  Standardized Interpretation of Chest Radiographs in Cases of Pediatric Pneumonia From the PERCH Study.

Authors:  Nicholas Fancourt; Maria Deloria Knoll; Breanna Barger-Kamate; John de Campo; Margaret de Campo; Mahamadou Diallo; Bernard E Ebruke; Daniel R Feikin; Fergus Gleeson; Wenfeng Gong; Laura L Hammitt; Rasa Izadnegahdar; Anchalee Kruatrachue; Shabir A Madhi; Veronica Manduku; Fariha Bushra Matin; Nasreen Mahomed; David P Moore; Musaku Mwenechanya; Kamrun Nahar; Claire Oluwalana; Micah Silaba Ominde; Christine Prosperi; Joyce Sande; Piyarat Suntarattiwong; Katherine L O'Brien
Journal:  Clin Infect Dis       Date:  2017-06-15       Impact factor: 9.079
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.